entertainment -WSS

entertainment

author：entertainment 2025-10-04 11:35:47 - browse：38224

Representative fluorescent multiplex immunohistochemistry colorful staining of healthy human colon. -- cancer coverage from STAT — Staining reveals different immune cells in a healthy human colon. Courtesy Olivia Newton-John Cancer Research institute

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations.

A new paper published in Science Immunologyon Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling their actions. The work, led by Australian researchers, helps unlock the long underappreciated role of these cells in cancer defense and could open new directions for developing immunotherapies for colorectal cancer, immunologists said.

Gamma-delta T cells have been “largely understudied” compared to their immune counterparts, alpha-beta T cells, said Ana Carrizosa Anderson, a cancer researcher at Harvard University who did not work on the study. “This study certainly helps cement the role of gamma-delta T cells in colon malignancy,” she said. “I think it provides a foundation for building understanding of some basic biology or some therapeutic approaches.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Abbott's new heart device gets FDA advisory panel nod

WSS

Congress considering partial increase for doctor pay in Medicare

2 million sign

The leaders of Italy and Poland say European Union should focus on stopping migration

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

Resistance to opioid

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

focus

entertainment

focus

Cancer drug shortages should be causing more outrage

The leaders of Italy and Poland say European Union should focus on stopping migration

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Report cites 'urgent' need to recruit more diverse clinical trial participants

How one medical school became remarkably diverse

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Tori Bowie and the unacceptable rates of Black maternal death

Why don't Americans have at

What does generative AI mean for health care? We asked experts

Condition critical? Britain's beloved but battered National Health Service turns 75

entertainment

Former New York Mayor de Blasio and wife announce separation, but not divorce

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Latigo launches with $135 million for Vertex

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

leisure time

hotspot

hotspot

leisure time